勃林格殷格翰能倍乐如何购买？

How to buy Boehringer Ingelheim Respimat? In July 2018, Sihehua® Respimat® (tiotropium bromide/olodaterol inhalation spray) was officially approved by the China Food and Drug Administration for the long-term maintenance treatment of patients with chronic obstructive pulmonary disease (including chronic bronchitis and emphysema). Respimat has been approved for marketing in China, so patients can buy the drug in China with a hospital prescription. In addition to the domestic Respimat, patients can also choose the version marketed abroad by Boehringer Ingelheim. The price is around 170$, which is very cost-effective. If necessary, patients can consult the Medical Partner Travel Overseas Medical Consulting Service Company for formal purchase methods.

COPD is a destructive chronic lung disease that gradually weakens the patient's respiratory function. It is known as the most "silent" invisible killer among respiratory diseases. Although it is named "Slow", the number of people suffering from it is increasing "rapidly" and it has become one of the main killers of Chinese people's health. The latest epidemiological survey results show that the current prevalence of COPD in people over 40 years old in my country is 13.7%, and the number of patients has reached approximately 100 million, making it the third most common chronic disease in China after hypertension and diabetes.

Results from a clinical development program presented at the 2017 American Thoracic Society International Meeting showed that the addition of tiotropium to Respimat® improved lung function and controlled asthma symptoms in children and adolescents compared with placebo. Regardless of their type of allergic asthma, the addition of Tiotropium Respimat® to their treatment improved airway obstruction in adults with symptomatic asthma compared with placebo, independent of body mass index (BMI). All analyzes showed that patients with previously uncontrolled asthma experienced improvement in respiratory symptoms when tiotropium was added to an ICS or ICS/LABA combination regimen. Recommended related articles: Note: The above information comes from the Internet and is compiled and edited by Medical Companion Travel (please correct me if there are any errors or omissions). It is only to provide information on the latest drugs on the market in the world and help Chinese patients understand the latest international new drug trends. It is only for internal discussion among medical staff and does not serve as any basis for medication. For specific medication guidelines, please consult the attending physician.